The inventions described below relate to the field of gas arthroscopy.
Arthroscopy of joints is a procedure performed nearly 8 million times per year and is done almost exclusively with fluid, particularly saline, to inflate a joint. (See R. T. Hegde, R. N. Avatgere; Air embolism during anesthesia for shoulder arthroscopy, BJA: British Journal of Anesthesia, Volume 85, Issue 6, 1 Dec. 2000, Pages 926-927.) Gas arthroscopy is not used because gas may travel along tissue planes and find its way into the venous system to cause embolisms or collect undesirably in locations distant from the surgical site. The problem with migration of gas from an arthroscopic joint space and the risks of air embolisms has previously been unsolved.
Gas arthroscopy has significant potential clinical utility for procedures where a fluid medium is undesirable, such as where surgical adhesives such as fibrin glues and cyanoacrylates are used, and other procedures where a wet environment inhibits adhesion or washes away the adhesive. The less desirable alternative to arthroscopy is an open procedure with the increased pain, scarring and recovery that goes with it.
The methods described below make gas arthroscopy a safe alternative to an open procedure where a dry environment is required. The method involves the use of a surgical sealant to prevent gas leakage from the joint during the procedure. Flowable biocompatible surgical sealants such as polyethylene glycol (PEG), polyethyleneimine (PEI), fibrin, albumin, or gelatin are injected into an arthroscopic joint space before insufflation with gas.
A tourniquet system for gas arthroscopy may also be used to inhibit extravasation of gas from an arthroscopic joint space. The tourniquet or cuff that surrounds the joint may also be used for a variety of joints to squeeze the tissue around the joint and restrict perfusion into the area for hemostasis.
As shown in
Various types of surgical sealants may be used, such as polyurethane, polyethylene glycol, polyvinyl alcohol, glucose, fibrin, gelatin, albumin, polysaccharides, chitosan, dextran, and chondroitin sulfate. A short acting sealant that dissolves and is absorbed without causing irritation to the joint would be most preferable. Chondroitin sulfate and other chemistry systems in this group are known to be biocompatible with joint tissue. Preferably the sealant would be of balanced viscosity to penetrate into the joint opening where gas would leak out, but stick to surfaces of the joint space. The sealant may be a gel, or a viscous liquid, or a lower viscosity fluid that may be cured if needed either by the mixing of the sealant with a static mixer before delivery, or with UV light. The sealant may also be loaded with anti-inflammatory medications such as steroids, anesthetics such as Marcaine, stem cells, or growth factors or other medications.
Though gas arthroscopy has been described, the method may be used in a liquid saline environment, for example for minimization of extravasation during arthroscopic surgery. The sealant would have to be biocompatible and not dissolve too quickly in water, for example PVA (polyvinyl alcohol) can be made water resistant.
In use, the surgeon injects the sealant into the knee joint and manipulates the joint to distribute the sealant. The sealant flows to fill holes, gaps and voids to form a barrier on the tissue defining the joint capsule. The joint space is inflated with gas. An arthroscope surgical procedure is performed. Upon completion of the procedure, the instruments are withdrawn and the gas escapes through the surgical portals.
Various medical procedures that are not possible in a liquid environment may be performed using this method. A gas-mediated procedure such as cartilage repair with a chopped cartilage conglomerate, biologic construct or cell-seeded membrane adhered in place with fibrin glue may be performed using a biologic delivery system. Ideally the use of fibrin glue is used in a gas environment rather than a saline environment since tissue adhesives do not adhere properly under water. The types of sheet biologics that can be delivered are: bioinductive collagen sheets for partial rotator cuff tears, structural patches for superior capsular reconstruction (SCR) procedures, and collagen construct sheets seeded with stem cells made by companies such as the MACI cartilage patch (Vericel, Ann Arbor Mich.) for repairing cartilage defects. Other procedures not possible in a liquid environment may be performed such as laser ablation of diseased cartilage and preparation of the implant site, or laser-based microfracture.
This dry arthroscopy system with a surgical sealant can facilitate a number of other procedures, such as delivery of bone cements for fracture repair, tacking down and repair of damaged cartilage and labral flaps, and repair of meniscal tears with adhesives instead of sutures. The system may also be used to repair partial rotator cuff tendon tears, and to adhere bioinductive repair constructs. The system and method may be used in other indications such as spinal procedures (where it is necessary to seal against cerebrospinal (CSF) fluid leaks), or neurosurgery where a sealed, dry surgical space needs to be created in a minimally-invasive way without an open surgical procedure. Another use for gas arthroscopy is when lasers are used that would otherwise be absorbed in a fluid medium (for example, use of a laser in a gas medium to perform microfracture is described in Kucklick, Method and Devices for Treating Damaged Articular Cartilage, U.S. Publ. No. 2009/0105792A1).
While the preferred embodiments of the devices and methods have been described in reference to the environment in which they were developed, they are merely illustrative of the principles of the inventions. The elements of the various embodiments may be incorporated into each of the other species to obtain the benefits of those elements in combination with such other species, and the various beneficial features may be employed in embodiments alone or in combination with each other. Other embodiments and configurations may be devised without departing from the spirit of the inventions and the scope of the appended claims.
This application claims priority to U.S. Provisional Patent Application 62/671,303 filed May 14, 2018.
Number | Name | Date | Kind |
---|---|---|---|
5720894 | Neev | Feb 1998 | A |
7572251 | Davison | Aug 2009 | B1 |
20040018228 | Fischell | Jan 2004 | A1 |
20180092645 | Bonutti | Apr 2018 | A1 |
20190125925 | Padua | May 2019 | A1 |
Number | Date | Country |
---|---|---|
WO-2004110512 | Dec 2004 | WO |
Number | Date | Country | |
---|---|---|---|
20190344022 A1 | Nov 2019 | US |
Number | Date | Country | |
---|---|---|---|
62671303 | May 2018 | US |